1. Ding, Liangfu, Zeng, Jilin, Zhao, Junyong. . Overexpression of SEZ6L2 and Immune Infiltration in Cancer Based on Gene Image Diagnosis. In Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 30, e70096. doi:10.1111/srt.70096. https://pubmed.ncbi.nlm.nih.gov/39360664/
2. Wang, Ziming, Lai, Jiaming, Liang, Lijian, Cheng, Quanyong, Zheng, Chaoxu. . Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma. In Translational cancer research, 9, 6768-6779. doi:10.21037/tcr-20-1527. https://pubmed.ncbi.nlm.nih.gov/35117286/
3. Konyukh, Marina, Delorme, Richard, Chaste, Pauline, Leboyer, Marion, Bourgeron, Thomas. 2011. Variations of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spectrum disorders and in human populations. In PloS one, 6, e17289. doi:10.1371/journal.pone.0017289. https://pubmed.ncbi.nlm.nih.gov/21394203/
4. Wang, Linhe, Ling, Xiangchao, Zhu, Caihui, Guo, Zhiyong, He, Xiaoshun. 2020. Upregulated Seizure-Related 6 Homolog-Like 2 Is a Prognostic Predictor of Hepatocellular Carcinoma. In Disease markers, 2020, 7318703. doi:10.1155/2020/7318703. https://pubmed.ncbi.nlm.nih.gov/32148567/
5. McKeon, Andrew, Lesnick, Connie, Vorasoot, Nisa, Dubey, Divyanshu, Mills, John. 2023. Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease. In Neurology(R) neuroimmunology & neuroinflammation, 10, . doi:10.1212/NXI.0000000000200145. https://pubmed.ncbi.nlm.nih.gov/37550073/
6. Chen, Long, Han, Sijia, Li, Yang, Zheng, Yanfu, Zhang, Qiang. 2022. SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer. In Experimental cell research, 417, 113194. doi:10.1016/j.yexcr.2022.113194. https://pubmed.ncbi.nlm.nih.gov/35523305/
7. Luo, Xue, Chen, Xinghong, Chen, Song, Yang, Huifang, Zhao, Daiwei. . High expression of SEZ6L2 as an independent prognostic Indicator in thyroid carcinoma. In Gland surgery, 11, 412-425. doi:10.21037/gs-22-37. https://pubmed.ncbi.nlm.nih.gov/35284305/
8. Zheng, Huajun, Zheng, Jianying, Shen, Yan. 2024. Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival. In Journal of gastrointestinal cancer, 55, 1291-1305. doi:10.1007/s12029-024-01085-9. https://pubmed.ncbi.nlm.nih.gov/38954188/
智鼠故事 
